- Raised $1.7M Seed round led by RAD BioMed, Oct 2017
- Raised $56k grant, May 2017
About
SynVaccine is an Israeli startup that develops vaccines based on synthetic biology. The company has developed a proprietary technology that identifies significant parts of viruses and designs vaccines containing these components to elicit an immune response while excluding hazardous elements. Their technology enables the design and fabrication of viral genomes using a safety-focused approach, aiming to overcome limitations of naturally occurring viruses or those developed through traditional methods. SynVaccine's approach combines synthetic biology, virology, bioinformatics, engineering, and robotics to create novel vaccines and potentially cancer immunotherapies. The company was founded based on commercialized research from Tel Aviv University and Weizmann Institute of Science, led by Prof. Tamir Tuller.
Funding history · 2 rounds · $1.8M total
Q&A
- What is SynVaccine's primary focus?
- SynVaccine develops vaccines based on synthetic biology, utilizing a CAD/CAM platform for designing and fabricating designer viruses for biotechnology.
- When was SynVaccine founded?
- SynVaccine was founded in July 2013.
- What is SynVaccine's employee count?
- SynVaccine has 1-10 employees.
- What is the total amount of funding SynVaccine has raised to date?
- SynVaccine has raised a total of $2,057,320 USD.
- When did SynVaccine last raise a Seed round?
- SynVaccine raised a Seed round in November 2017, securing $1,700,000 USD.
- What is the most recent funding event for SynVaccine?
- SynVaccine had a Secondary Round in June 2025.
- Who are the co-founders of SynVaccine?
- The co-founders of SynVaccine are Tamir Tuller and Tuval Ben Yehezkel.
- What is SynVaccine's primary sector?
- SynVaccine's primary sector is Health Tech & Life Sciences.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | synvaccine.com |
|---|
Identifiers & details
| Founded | 2013-7 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 3 |
|---|
Web history (Wayback)
| Domain | synvaccine.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514942291 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2013-07-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | גולדה מאיר 3 נס ציונה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-15 | דו~ח שנתי |